Although we did not characterize the specific sources of ROS in the present
study, our metabolomics dataset supports the role of mitochondrial dysfunction
as a major source during both acute and chronic injury stages. Interestingly, we
identified glutathione (GSH) metabolism as a molecular target of dietary
LC-O3PUFAs. For instance, the animals receiving the dietary intervention showed
increased spinal cord levels of γ-glutamylglutamine, cystathione,
hippurate, GSH, and GSSH, suggesting increased production and/or reduced
depletion of antioxidant pools after SCI. Notably, the levels of heme were
increased in the spinal cord of rats exposed to the LC-O3PUFA-rich diet,
proposing a novel protective mechanism for LC-O3PUFAs. Similar to the findings
observed in sham rats, LC-O3PUFAs altered the TCA and Urea cycle. The increased
levels of purine nucleotides and acetyl-lysine suggests a mechanism for which
chronic dietary supplementation with LC-O3PUFAs modulates plasticity, growth,
and gene expression. Metabolites in red increased with the dietary intervention.
Features in green decreased with the LC-O3PUFA diet when compared to controls.
Putative enzymatic and protein targets are highlighted in red ovals.
Abbreviations: 5-OPase, 5-oxoprolinase; Arg1, arginase; CYGB, cytoglobin;
cys-gly, cysteine-glycine; GSH, glutathione, reduced; GSSH, glutathione
disulfide, oxidized; GCL, γ-glutamylcysteine ligase; GS, glutathione
synthase; GPx, glutathione peroxidase; GR, glutathione reductase; GST,
glutathione-S-transferase; γGT, γ-glutamyltransferase; GCT,
γ-glutamylcylotransferase; MTA, 5′-methylthioadenosine; Ngb,
neuroglobin; TCA, tricarboxylic acid.